Navigation Links
Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer
Date:5/12/2009

ion will consist of (i) $200 in cash, and (ii) a number of shares of Common Stock with a value equal to the Exchange Consideration minus $200 (the "Common Stock Portion", and such number of shares of our Common Stock being the "Common Stock Consideration"). The number of shares of Common Stock received by holders as part of the Exchange Consideration will equal the quotient obtained by dividing (x) the Common Stock Portion by (y) the average of the daily volume weighted average price of the Common Stock on the national securities exchange on which the Common Stock is listed or quoted for trading as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)) for the 10 trading days from and including May 19, 2009 to and including June 2, 2009 (the "10-day VWAP"). The Company will announce the 10-day VWAP prior to the opening of trading on June 3, 2009. Accrued and unpaid interest on Notes validly tendered and not withdrawn, up to, but not including, the date of exchange, will be exchanged for that number of shares of Common Stock determined by dividing (1) the amount of accrued and unpaid interest on a Note, by (2) the 10-day VWAP, and as further described herein. However, in no event will the aggregate number of shares of Common Stock Consideration plus the aggregate number of shares of Common Stock to be exchanged for accrued and unpaid interest exceed a maximum number of shares of our Common Stock (the "Common Stock Limit") to be disclosed in the Schedule TO (including the Offer to Exchange and related Letter of Transmittal) that will be filed by the Company with the Securities and Exchange Commission ("SEC"). In the event the aggregate number of shares of Common Stock Consideration plus the aggregate number of shares of Common Stock to be exchanged for accrued and unpaid interest exceeds the Common Stock Limit, the Company will terminate the Exchange Offer.

The description of the Ex
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
2. Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
3. Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009
4. Orexigen(R) Therapeutics to Speak at Upcoming Conferences
5. Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results
6. Nektar Therapeutics Reports First Quarter 2009 Financial Results
7. Cell Therapeutics, Inc. (CTI) to Report 2009 First Quarter Financial Results on May 7
8. Arno Therapeutics to Deregister its Common Stock under the Exchange Act
9. TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
10. United Therapeutics Reports First Quarter 2009 Financial Results
11. Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  Smith & Nephew (LSE:SN, NYSE: ... business, today announced its entry into the forefoot ... Toe Repair System. Comprised of three separate repair ... (MTP) ligament repair and reconstruction, a metatarsal osteotomy ... Inter-phalanges (PIP) fusion, also known as hammer toe ...
(Date:7/31/2014)... Held at the Stanford Cancer Center, ... of the disease and its treatment. Survivors will find ... well as updates on the state-of-the-art with respect to ... for organizing this educational opportunity,” says KCA CEO Bill ... her colleagues have put together a program that balances ...
(Date:7/31/2014)... The global market for molecular diagnostics is ... to a new study by Grand View Research, Inc. ... subsequent introduction of advanced cancer diagnostic technologies are expected ... next six years. Moreover, the growing global base of ... with disease triggering lifestyle habits such as smoking and ...
(Date:7/31/2014)... IL (PRWEB) July 31, 2014 ... of automation across the U.S., increasing unemployment, depressing ... class. It is a Catch 22—we need ... but this means fewer jobs,” says economist and ... just-released Pollina Corporate Top 10 Pro-Business States for ...
Breaking Biology Technology:Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4
... Alliance, the leading,management consulting firm specializing in ... Doug Linton has joined its Executive,Advisory Group. ... professionals brought,together by Campbell Alliance CEO John ... engagements. Mr. Linton will focus on,distribution-related issues, ...
... Examined 175,000 Teenage Girls and Adult Women, ... than doubled in six years among teenage and ... in the May issue of Diabetes Care., http://care.diabetesjournals.org/ ... at gestational diabetes,(diabetes that develops during pregnancy, then ...
... April 25 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ) ... Stock Market ("Nasdaq") stating that the Company is not ... continued,inclusion on the Nasdaq Global Market pursuant to Marketplace ... letter dated April 22,2008, is a standard communication when ...
Cached Biology Technology:Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group 2Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group 3Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 2Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 3Kaiser Permanente Study Finds Diabetes Doubling Before Motherhood 4Keryx Biopharmaceuticals Receives Nasdaq Notification 2Keryx Biopharmaceuticals Receives Nasdaq Notification 3
(Date:7/31/2014)... . , Metal-organic ... sponge that soaks up liquids. Hence, these highly porous ... However, loading of many MOFs is inhibited by barriers. ... in Nature Communications that the barriers are ... be prevented by water-free synthesis and storing strategies. ...
(Date:7/31/2014)... Since Alexandre Edmond Becquerel first discovered the photovoltaic effect ... harness the power of sunlight for its own purposes. ... 2014 issue of the FASEB Journal ... exploiting the power of sunlight by focusing on a ... conserved throughout evolution. This conservationor persistence over time and ...
(Date:7/31/2014)... LA Dr. Oren Tessler, Assistant Professor of Clinical ... of Medicine, is part of a team of plastic ... using a method to screen and select patients for ... of the patients who underwent this surgery to decompress ... got a bonus cosmetic eyelid surgery. The study, which ...
Breaking Biology News(10 mins):Free pores for molecule transport 2Scientists shine bright new light on how living things capture energy from the sun 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2
... are reporting "a significant step forward" in proving the feasibility ... oceans for exotic new life forms. Their description of successful ... autonomous seafloor lander equipped with a mini-laboratory the size of ... traces of DNA in the deep oceans appears in ...
... A type of MRSA found in humans originated in cattle at ... provides clear evidence that livestock were the original source of an ... the genetic make-up of more than 40 strains of a bacterium ... antibiotic resistance to develop into MRSA. At least two genetic ...
... Leaders from government, industry, academia and patient advocacy organizations ... Topics include identifying actions to improve the medical and health ... securing efficient patient-centric health care delivery and exploring ways to ... WHO: ...
Cached Biology News:Cattle can be a source of MRSA in people, scientists find 2Meeting: Straight Talk: The Future of Medical and Health Research 2
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... is an aqueous solution that contains a ... in a PBS buffer (phosphate buffered saline), ... contains a combination of 0.02% methylisothiazolone and ... Plus Stabilizer provides optimum performance for both ...
... K28/86.2, PDZ Domain GenBank Accession ... GST fusion to residues 77-299 of ... pH 7.4, 0.075M NaCl containing 0.05% ... by immunoblot on rat brain microsomal ...
... 20 Plasma Immunodepletion Kit specifically removes 20 ... plasma or serum in preparation for further ... into the plasma proteome whether you use ... chromatography or go straight to mass spectrometry. ...
Biology Products: